Phillips 66 PSX reported Q2 adjusted EPS of $3.87, beating the consensus of $3.54.
Revenue of $35.74 billion exceeded the consensus of $34.55 billion.
Midstream segment adjusted pre-tax income stood at $626 million, vs. $678 million in Q1 2023, with restructuring costs of $22 million related to the integration of DCP Midstream.
The Chemicals segment adjusted pre-tax income was $192 million vs. $198 million in Q1, with global olefins and polyolefins utilization standing at 98%.
The Refining segment adjusted pre-tax income stood at $1.1 billion (vs. $1.6 billion in Q1) on a $14 million loss related to a sale of assets.
Marketing and Specialties segment adjusted pre-tax income rose to $644 million from $426 million, led by higher global marketing margins on strong demand.
Operating cash flow stood at $1.0 billion in the quarter.
The company returned $1.8 billion to shareholders through dividends and share repurchases in Q2.
Since July 2022, the company has returned $5.4 billion to shareholders through share repurchases and dividends, with a target of shareholder distributions of $10 billion to $12 billion by year-end 2024.
Capital expenditures and investments stood at $551 million in Q2.
As of June 30, 2023, PSX had $3.0 billion of cash and cash equivalents and committed capacity available under credit facilities worth $5.6 billion.
The company says the business transformation is on track to deliver run-rate savings of $1 billion by end-2023.
As of June 30, the company has achieved $750 million of run-rate savings initiatives, which includes sustaining capital efficiencies of $200 million.
M&A: In Q2, the company closed the $3.8 billion acquisition of DCP Midstream, LP. This increased total economic interest to around 87%, which is expected to generate an incremental annual adjusted EBITDA of $1 billion.
Price Action: PSX shares are trading lower by 1.48% at $110.45 premarket on the last check Wednesday.
Now Read: Caterpillar Will Give You $500 Per Month As The Stock Hits All-Time Highs: Here's How
Photo: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.